Prague Med. Rep. 2012, 113, 58-65

Heart Failure Treated with Low-dose Milrinone in a Full-term Newborn

S. Šebková1, V. Tomek2, P. Zemanová1, Jan Janota1,3

1Department of Neonatology, Thomayer Hospital, Prague, Czech Republic
2Kardiocentrum and Cardiovascular Research Centre, University Hospital Motol, Prague, Czech Republic
3Institute of Pathological Physiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Received September 23, 2011
Accepted January 16, 2012


1. Alpan, G. (2009) Persistent pulmonary hypertension of the newborn. In: Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs, 6th Edition. Gomella, T. L., Cunningham, M. D., Eyal, F. G., Tuttle, D., pp. 636–644, McGraw-Hill, New York.
2. Anderson, A. L. (2009) Commonly used medications. In: Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs, 6th Edition. Gomella, T. L., Cunningham, M. D., Eyal, F. G., Tuttle, D., pp. 729–787, McGraw-Hill, New York.
3. Bassler, D., Choong, K., McNamara, P., Kirpalani, H. (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol. Neonate 89(1), 1–5. <>
4. Bassler, D., Kreutzer, K., McNamara, P., Kirpalani, H. (2010) Milrinone for persistent pulmonary hypertension of the newborn. Cochrane Database Syst. Rev. 10(11), CD007802.
5. Bayrakci, B., Josephson, C., Fackler, J. (2007) Oxygenation index for extracorporeal membrane oxygenation: is there predictive significance? J. Artif. Organs 10(1), 6–9. <>
6. Bengur, A. R., Meliones, J. N. (1998) Cardiogenic shock. New Horiz. 6(2), 139–149.
7. Betit, P., Craig, N. (2009) Extracorporeal membrane oxygenation for neonatal respiratory failure. Respir. Care 54(9), 1244–1251. <>
8. Chen, B., Lakshminrusimha, S., Czech, L., Groh, B. S., Gugino, S. F., Russel, J. A. (2009) Regulation of phosphodiesterase 3 in the pulmonary arteries during the perinatal period in sheep. Pediatr. Res. 66(6), 682–687. <> <PubMed>
9. Danhaive, O., Margossian, R., Geva, T., Kourembanas, S. (2005) Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates. J. Perinatol. 25, 495–499. <>
10. Greenough, A., Milner, A. D. (2005) Pulmonary disease of the newborn: Acute respiratory disease. In: Roberton’s Textbook of Neonatology, 4th Edition. Rennie, J. M., Elsevier, London.
11. Hoffman, T. M., Wernovsky, G., Atz, A. M., Kulik, T. J., Nelson, D. P., Chang, A. C., Bailey, J. M., Akbary, A., Kocsis, J. F., Kaczmarek, R., Spray, T. L., Wessel, D. L. (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7), 996–1002. <>
12. Hsu, D. T., Pearson, G. D. (2009) Heart failure in children: part I: history, etiology, and pathophysiology. Circ. Heart Fail. 2(1), 63–70. <>
13. Kinsella, J. P. (2006) Inhaled nitric oxide therapy. In: Manual of Neonatal Respiratory Care, 2nd Edition. Donn, S. M., Sinha, S. K., pp. 426–427, Mosby, Philadelphia.
14. McMahon, C. J., Murchan, H., Prendiville, T., Burch, M. (2006) Long-term support with milrinone prior to cardiac transplantation in neonate with left ventricular noncompaction cardiomyopathy. Pediatr. Cardiol. 28(4), 317–318. <>
15. McNamara, P., Laique, F., Muang, S., Whyte, H. (2006) Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J. Crit. Care 21(2), 217–222. <>
16. Paradisis, M., Jiang, X., McLachlan, A. J., Evans, N., Kluckow, M., Osborn, D. (2007) Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 92(3), F204–F209. <> <PubMed>
17. Paradisis, M., Evans, N., Kluckow, M., Osborn, D. (2009) Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J. Pediatr. 154(2), 189–195. <>
18. Rapundalo, S. T., Grupp, I., Grupp, G., Matlib, M. A., Solaro, R. J., Schwartz, A. (1986) Myocardial actions of milrinone: characterization of its mechanism of action. Circulation 73(3), 134–144.
19. Sehgal, A. (2011) Haemodynamically unstable preterm infant: an unresolved management conundrum. Eur. J. Pediatr. 170(10), 1237–1245. <>
20. Sehgal, A., Francis, J. V., Lewis, A. I. (2011) Use of milrinone in the management of haemodynamic instability following duct ligation. Eur. J. Pediatr. 170(10), 115–119. <>
21. Stayer, S. A., Liu, Y. (2010) Pulmonary hypertension of the newborn. Best Pract. Res. Clin. Anaesthesiol. 24(3), 375–386. <>
22. Tanaka, H., Tajimi, K., Moritsune, O., Kobayashi, K., Okada, K. (1991) Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Crit. Care Med. 19(1), 68–74. <>
23. Tzialla, C., Cerbo, R. M., Perotti, G., Stronati, M. (2010) Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide-treated with milrinone: a case report. Turk. J. Pediatr. 52(1), 78–80.
24. Zuppa, A. F., Nicolson, S. C., Adamson, P. C., Wernovsky, G., Mondick, J. T., Burnham, N., Hoffman, T. M., Gaynor, J. W., Davis, L. A., Greeley, W. J., Spray, T. L., Barrett, J. S. (2006) Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth. Analg. 102(4), 1062–1069. <>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)